Young accountants are drawn to these top firms by their prioritization of work-life balance, flexibility, unique talent development models and opportunities for leadership.
Pfizer is calling upon lessons learned from one of the first drugs ever made available on the internet—Viagra—as it commercializes a new obesity drug in China.
Neurocrine Biosciences will conduct a new study for the rare disease drug Vykat to explore dosing and safety in patients with Prader-Willi syndrome who have complex health issues.
Novartis is discontinuing a neurodegeneration alliance with BioArctic in which the companies aimed to develop a drug candidate that could cross the blood-brain barrier.
Sales of assets from Seagen and Biohaven grew in the third quarter, but it wasn’t enough for Pfizer to overcome declines across the Prevnar and COVID franchises.
BDO’s strategy of merging member firms into larger groups means it doesn’t need to take private equity investment to grow, said the network’s new global head, Trond-Morten Lindberg, as more accounting and consulting services lean on external funding.
While private credit and other alts can offer high returns, advisors should know about the logistics involved, which could lead to tax headaches for clients.
The update would help determine whether equity-linked contracts, such as warrants, are indexed to an entity’s own stock and potentially classified as equity.
Levvy announced the availability of new AI features and capacities for firm efficiency and revenue opportunities, intended to address much of the ad hoc administrative work that tends to eat into professionals’ time.